
Most Malaysian women still unaware
The National Cancer Society Malaysia (NCSM) managing director said many women wrongly believe they are not at risk because they feel healthy.
'The gap lies in the perception that I'm healthy, so I don't see the need for vaccination or screening.
'Another issue is ignorance – many assume HPV is only spread through sex, and since they have only one partner, they believe they're not at risk,' he said.
He was responding to Health Minister Datuk Seri Dr Dzulkefly Ahmad's statement that more than 10,500 Malaysian women tested positive for HPV over the past five years through cervical cancer screening efforts.
Dr Murallitharan also said many women are willing to spend on spas or beauty treatments but hesitate to invest in health screenings or vaccinations.
He said following the success of the 'Leaving No One Behind' HPV vaccination programme last year, NCSM plans to partner with general practitioners to offer 70% subsidies for screenings.
'We are changing our approach. Instead of waiting for patients to come to us, we'll go to them,' he said.
Echoing the concern, Malaysian Council for Child Welfare advisor Datuk Dr Raj Abdul Karim said many women do not take their health seriously enough.
'Many women don't realise that silent blood pressure or diabetes affects your health and even cancer can be invisible at times.
'As such, we need more advocacy and programmes for women on this, to emphasise that even if they feel well, they still need to get screening,' she added.
She said the HPV vaccine can prevent high-risk strains linked to cervical cancer.
'So we need to accelerate the intake of the vaccine and have access to more screening among women, since cervical cancer is preventable,' she added.
Dr Raj also recommended regular Pap smears for women aged 20 to 50, especially those who are sexually active.
She said HPV DNA self-sampling could help eliminate cultural taboos and expand access for rural and vulnerable groups.
Women's Aid Organisation executive director Nazreen Nizam said the conversation must shift from blaming women to addressing the systemic inequalities that limit access to healthcare.
She said despite the introduction of the HPV vaccine in 2019, the lack of consistent and widespread public education has left many women unaware of its importance or how to access it.
'The government must invest in sustained, multilingual and culturally relevant public awareness campaigns, and ensure that screening services and vaccines are free or subsidised for all women, regardless of their citizenship or location.
'One possibility is to introduce age-based automatic subsidies for screenings, integrated into existing public healthcare systems and even GP clinics, so that it becomes part of routine care.
'But access alone isn't enough – the healthcare environment must also be safe, non-judgmental and respectful of women's autonomy and lived realities,' she said.
HPV is the leading cause of cervical cancer, and any sexually active person can contract it.
In Malaysia, cervical cancer is the second most common cancer among women aged 15 to 44.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


New Straits Times
8 hours ago
- New Straits Times
Price labelling rule stays: MoH prioritises education over penalties
PUTRAJAYA: The Health Ministry (MoH) will continue focusing on education and awareness in enforcing the Price Control and Anti-Profiteering (Medicine Price Labelling) Order 2025, despite a pending judicial review application challenging the regulation. Health Minister Datuk Seri Dr Dzulkefly Ahmad said the ministry respected the legal process but was committed to ensuring smooth implementation of the order through educational enforcement. "We will continue with this approach to avoid enforcement gaps while the court process is ongoing," he told reporters after officiating the 2025 National Health Technology Assessment Conference and the 30th anniversary of the Malaysian Health Technology Assessment Section (MaHTAS) here today. The regulation, which came into force on May 1, mandates all private clinics and community pharmacies to display medicine prices on shelves, in catalogues or on written price lists, under the Price Control and Anti-Profiteering (Medicine Price Labelling) Order 2025. Dzulkefly was responding to reports that the Malaysian Medical Association (MMA) and seven other organisations have applied for leave to initiate a judicial review of the order. Among the applicants are the Sabah Private Practitioners Association (APPS), the Malaysian Association for the Advancement of Functional and Interdisciplinary Medicine (MAAFIM), the Malaysian Muslim Doctors Association (PERDIM), and the Federation of Private Medical Practitioners' Associations Malaysia (FPMPAM). On May 4, Dzulkefly had clarified that no fines or compounds would be issued during the first three months of enforcement, as the ministry's priority was on stakeholder education. As of now, neither MoH nor the Domestic Trade and Cost of Living Ministry has announced an extension to the grace period, which ends tomorrow (July 31). – BERNAMA


New Straits Times
8 hours ago
- New Straits Times
MoH open to reclassifying etomidate under Dangerous Drugs Act
PUTRAJAYA: The Health Ministry (MoH) is open to reviewing the proposal to list 'etomidate' under the Dangerous Drugs Act 1952 following reports of its frequent abuse, its minister Datuk Seri Dr Dzulkefly Ahmad said. He said that based on current clinical practices, the MoH was always ready to carry out evaluations or studies based on evidence presented by any party. Etomidate is currently listed under the Poisons Act 1952. "Any proposal can be considered, but at the end of the day, I look at the evidence base when evaluating something," he told a press conference after officiating the 2025 National Health Technology Assessment Conference and the 30th Anniversary Celebration of the Health Technology Assessment Section (MaHTAS) here today. Bandar Kuching MP Dr Kelvin Yii had before this urged the government to list etomidate under both the Poisons Act 1952 and the Dangerous Drugs Act 1952, citing reports of its fatal effects in Singapore. He said etomidate was an intravenous anaesthetic that had been misused as a recreational substance through vape products, often marketed as 'Kpods'. Kpods is a street term that usually refers to vape pods laced or contaminated with harmful chemicals or synthetic drugs, rather than just regular vape liquids like nicotine or flavouring. In a related development, Dzulkefly said the government is currently reviewing a proposal to ban e-cigarettes or vapes in the country. "I'm taking note, but I don't want to act hastily. We are taking this very seriously, and it needs to go through a thorough evaluation and consideration of legal and public health impacts," he said. – BERNAMA


New Straits Times
11 hours ago
- New Straits Times
Manulife Malaysia boosts cancer prevention with new insurance plans
KUALA LUMPUR: Life insurer Manulife Malaysia is deepening its commitment to cancer prevention through insurance-led health protection. Chief Marketing Officer Marilyn Wang said the initiative is aimed at supporting Malaysians at every stage of their health journey. "We want to be more than just a claims processor. We aim to be a true health partner, driving awareness, encouraging early detection, supporting during treatment, and continuing care after recovery," she said in a media briefing today. Wang also said that this commitment is reflected in Manulife's flagship products, Manulife HealthSave Enrich (MHSE) and Beyond Critical Cover (BCC). "Both MHSE and BCC are designed to address gaps in health literacy, vaccine uptake, and post-diagnosis care. "MHSE includes coverage for preventive vaccinations such as human papillomavirus (HPV), dengue, and influenza. It also offers a no-claims discount of up to 40 per cent, outpatient care benefits, post-cancer recovery support, and annual coverage of up to RM20 million for families," said Wang. Meanwhile, BCC provides upfront financial payouts upon diagnosis for 48 covered critical illnesses, along with additional support for intensive care unit (ICU) admissions and extended hospital stays. Wang said this approach is backed by findings from its Asia Care Survey 2024. The study revealed that 45 per cent of Malaysians are worried about cancer, and 71 per cent feel underinsured when it comes to the cost of treatment. "Most people are not aware that HPV vaccines are available for free in public schools. We want to help change that by spreading awareness, not just about protection, but about taking action before it is too late," she said. Manulife's initiative also aligns with the work of Cancer Research Malaysia (CRM), which focuses on tackling cancer through regional research and development. According to the Department of Statistics Malaysia, cancer is now the fourth leading cause of death nationwide. CRM projects that cancer incidence will double by 2040, with one in nine women and one in ten men expected to be diagnosed in their lifetime.